v3.25.1
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net Sales $ 1,909.1 $ 1,889.2
Type of Revenue [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization $ 549.8 $ 512.3
Type of Cost, Good or Service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember
Intangible asset amortization $ 151.0 $ 142.1
Research and development 110.6 107.9
Selling, general and administrative 758.8 736.2
Restructuring and other cost reduction initiatives 36.0 124.4
Acquisition, integration, divestiture and related 10.6 0.4
Operating expenses 1,616.8 1,623.3
Operating Profit 292.3 265.9
Other income (expense), net 2.9 (0.1)
Interest expense, net (66.2) (50.7)
Earnings before income taxes 229.0 215.1
Provision for income taxes 46.5 42.3
Net Earnings 182.6 172.8
Less: Net earnings attributable to noncontrolling interest 0.6 0.4
Net Earnings of Zimmer Biomet Holdings, Inc. $ 182.0 $ 172.4
Earnings Per Common Share    
Basic $ 0.92 $ 0.84
Diluted $ 0.91 $ 0.84
Weighted Average Common Shares Outstanding    
Basic 198.9 205.2
Diluted 199.7 206.2